Nabil Noureddin
@NoureddinNabil
Followers
356
Following
2K
Media
30
Statuses
183
Advanced endoscopy fellow @WCM_GI via @UCSD_GI & @unlvmedicine
Joined November 2019
Happy for the graduating IM residents and can’t wait to see their future accomplishments. I am grateful to @ucsdim for the Top Fellow award. It was an honor to work with an outstanding group of residents! .#GITwitter
12
4
69
RT @AmJGastro: Local Post-Procedural Cryoprevention Significantly Reduces the Incidence of Post-ERCP Pancreatitis.Azuma, et al. 📕 https:/….
0
104
0
Huge step forward for MASH patients — and for the hepatology field!.
New in the @TheLancet :Arguably the highest fibrosis improvement in #MASH trials to date #livertwitter @ebtapper @schattenbergJ @AlkhouriNaim @akerotx @scottisaacsmd @NoureddinNabil @ArunJSanyalVCU .Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic.
0
0
7
A breakthrough study for our MASH patients! @NoureddinMD.
SYMMETRY trial: Efruxifermin was previously shown to reduce fibrosis in patients with stage 2 or 3 fibrosis caused by metabolic dysfunction–associated steatohepatitis. Research findings in patients with compensated cirrhosis are summarized in a new Quick Take video.
0
0
9
RT @NEJM: SYMMETRY trial: Efruxifermin was previously shown to reduce fibrosis in patients with stage 2 or 3 fibrosis caused by metabolic d….
0
21
0
RT @NoureddinMD: Combination.Therapy of TERN-501 and TERN-101 (THR-B and FXR) are now published @NatureMedicine @AlkhouriNaim @DrLoomba….
nature.com
Nature Medicine - In the 12-week, phase 2a DUET study, treatment with TERN-501, a thyroid hormone receptor β agonist, as monotherapy or in combination with TERN-101, a farnesoid X receptor...
0
7
0
RT @GIE_Journal: In Articles in Press: "Establishing standards of practice for endoscopic sleeve gastroplasty" by Pichamol Jirapinyo et al.….
0
3
0
RT @AlkhouriNaim: @NoureddinMD presenting the most important data at the @EASLnews #ILC2025 meeting. Reversal of cirrhosis is possible!! Am….
0
11
0
RT @schattenbergJ: Did you know that #compensated #cirrhosis in MASH can be reversed from pharmacological treatment ⁉️. Shown at @EASLedu @….
0
14
0
RT @ebtapper: Important study in @NEJM .❤️ seeing @NoureddinMD front page!.😁for treatments to reverse #cirrhosis.⚠️careful not to over inte….
0
43
0
Had a great time participating in @FITE_endoscopy debates this year. Grateful for the chance to share our perspective and learn from others! @SighPichamol @AhmadBazarbashi @JasonSamarasena @HarshitKharaMD @ThomasRMcCarty3 @DDWMeeting
1
1
11
Thankful to attend the POEM hands-on course by @OlympusMedUS , guided by Drs. Peter Draganov and @joohahwang . The in vivo training provided valuable insights into different technique. @CFS_UCSD
0
0
17
RT @ebtapper: Today we had @NoureddinMD visit for grand rounds. Over the course of 45 minutes he gave a masterful overview of MASLD, noninv….
0
4
0
RT @juanpabloarab: Agree! My friend @NoureddinMD is the real deal! @AASLDtweets #TLM24 #LiverTwitter.
0
2
0
RT @BlaneyMD: Walking us through the MASH pipeline with THE @NoureddinMD at the PG course. As always, it’s an exciting time to be a hepat….
0
5
0
0
1
0
RT @Echosens: 🔍 @NoureddinMD on the role of FibroScan® in evaluating if Rezdiffra™ is right for patients (via @HealioGastro):.Step 1: Confi….
healio.com
With the FDA label for Rezdiffra excluding the need for liver biopsy, experts proposed recommendations to “fill the gap” on how to leverage noninvasive tests to assess treatment response in metabolic...
0
3
0
RT @AmerGastroAssn: It’s time to celebrate! 🎉 Congratulations to this year’s graduating gastroenterology fellows on completing their traini….
0
9
0
Thank you so much @MaryLKrinskyDO for your mentorship and support!!.
🙌🎉🎓Congratulations @UCSD_GI to our graduating fellows! Another awesome class! So proud of all of you! @laurellbranch @NoureddinNabil
1
1
22